The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia

por Backes, James, Anzalone, Deborah, Hilleman, Daniel, Catini, Julia
Publicado 2016

PB2150: CARDIAC AMYLOID REACHING FOR EXTENDED SURVIVAL (CARES) TRIALS: 2 PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED, PHASE 3 TRIALS ASSESSING CAEL-101 IN PATIENTS WITH MAYO STAGE...

por Wechalekar, Ashutosh, Palladini, Giovanni, Molina, Maria Angelica, Kastritis, Efstathios, Ianus, Juliana, Catini, Julia, Quarta, C Cristina, Liedtke, Michaela
Publicado 2023

S204: SAFETY AND TOLERABILITY OF CAEL-101, AN ANTI-AMYLOID MONOCLONAL ANTIBODY, COMBINED WITH ANTI-PLASMA CELL DYSCRASIA THERAPY IN PATIENTS WITH LIGHT-CHAIN AMYLOIDOSIS: 18-MONTH...

por Valent, Jason, Liedtke, Michaela, Zonder, Jeffrey, Molina, Maria Angelica, Udata, Chandrasekhar, Ianus, Juliana, Tripptree, John, Catini, Julia, Quarta, C Cristina
Publicado 2023

Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy

por Quarta, C. Cristina, Fontana, Marianna, Damy, Thibaud, Catini, Julia, Simoneau, Damien, Mercuri, Michele, Garcia-Pavia, Pablo, Maurer, Mathew S., Palladini, Giovanni
Publicado 2022